Surgalign (NASDAQ:SRGA) Downgraded by Zacks Investment Research to Hold

Surgalign stock has undergone multiple analysts rating changes in the recent past.  Surgalign Downgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

Shares of Surgalign traded down -$0.01 on Tuesday, reaching $1.01. 0 shares of the stock traded hands, compared to its average volume of 2803849. Shares of Surgalign were trading at $1.01 on Tuesday. The firm’s 50 day moving average is $1.22 and its 200 day moving average is $1.73.Surgalign has a 12 month low of $1.01 and a 12 month high of $3.27. While on yearly highs and lows, Surgalign’s today has traded high as $1.06 and has touched $1.01 on the downward trend. See More Analyst Rating at: RATING

Surgalign Earnings and What to expect: 

Surgalign last announced its earnings data on August 6th, 2021. The reported ($0.09) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.03. The firm had revenue of $24.83 million for the quarter, compared to analysts’ expectations of $24.53 million. Surgalign has generated ($0.51) earnings per share over the last year ($0.11 diluted earnings per share) and currently has a price-to-earnings ratio of 9.2. Earnings for Surgalign are expected to grow in the coming year, from ($0.40) to ($0.31) per share. Surgalign has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, November 10th, 2021 based off prior year’s report dates.

Earnings for Surgalign are expected to grow in the coming year, from ($0.40) to ($0.31) per share. The P/E ratio of Surgalign is 9.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 14.78. The P/E ratio of Surgalign is 9.23, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 32.66. Surgalign has a P/B Ratio of 3.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Surgalign (NASDAQ:SRGA) Moving Average Technical Analysis

5 day Moving Average is $1.03 And 5 day price change is -$0.02 (-1.46%)  with average volume for 5 day average is 1,069,800. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $1.18 and 20 day price change is -$0.41 (-28.52%) and average 20 day moving volume is 2,310,720. 50 day moving average is $1.22  and 50 day price change is -$0.12 ( -10.18%)  and with average volume for 50 days is : 4,632,394. 200 day moving average is $1.73  and 200 day price change is -$1.55 (-60.35%)  and with average volume for 200 days is : 2,927,854.

Other owners latest trading in Surgalign :

  • On 8/26/2021 shares held by Y Intercept Hong Kong Ltd were 22,673 which equates to market value of $32K and appx 0.00% owners of Surgalign
  • On 8/23/2021 shares held by Morgan Stanley were 2,804,186 which equates to market value of $3.90M and appx 0.00% owners of Surgalign
  • On 8/17/2021 shares held by Wells Fargo & Company MN were 30,675 which equates to market value of $43K and appx 0.00% owners of Surgalign
  • In total Institutional ownership equates to Institutional Ownership Percentage: 52.73% for Surgalign

See More Analyst Rating at: RATING